| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/07/2001 | WO2001039763A2 Use of methylol-containing compounds for the manufacture of a medicament for the treatment of tumors |
| 06/07/2001 | WO2001039762A2 Use of taurolidine or taurultam for the manufacture of a medicament for the treatment of tumors of the central nervous system |
| 06/07/2001 | WO2001039750A1 Effervescent histamine h2 antagonist composition |
| 06/07/2001 | WO2001039742A2 Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| 06/07/2001 | WO2001039724A2 Phosphonate compounds |
| 06/07/2001 | WO2001039723A2 Triazospiro compounds having nociceptin receptor affinity |
| 06/07/2001 | WO2001028557B1 Cannabimimetic indole derivatives |
| 06/07/2001 | WO2001018028A8 Novel c13-substituted estra-1,3,5(10)-triene-3-yl-sulfamates, a method for producing the same and pharmaceutical compositions containing these compounds for inhibiting oestrone sulfatase |
| 06/07/2001 | WO2001015553B1 Dietary food supplement containing natural cyclooxygenase inhibitors |
| 06/07/2001 | WO2001012187A3 Benzoic acid derivatives and their use as ppar receptor agonists |
| 06/07/2001 | WO2001010894A3 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 06/07/2001 | WO2001007612A3 Receptors and associated proteins |
| 06/07/2001 | WO2000069424A3 Method of treating psychotic disorders |
| 06/07/2001 | WO1999063940A3 INHIBITORS OF H+K+-ATPase |
| 06/07/2001 | US20010002998 Over-coated chewing gum formulations including tableted center |
| 06/07/2001 | DE19958460A1 Verfahren zur Herstellung von Epinastine-Hydrochlorid in der hochschmelzenden Kristallmodifikation Process for preparing epinastine hydrochloride in the high-melting crystal modification |
| 06/07/2001 | DE19958388A1 Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten Triazinone compounds for the treatment of diseases caused by infestation with parasitic protozoa |
| 06/07/2001 | DE19958153A1 Oxazolidinon-Derivate Oxazolidinone derivatives |
| 06/07/2001 | DE19957916A1 Neue Proteinkonjugate und Verfahren zu deren Herstellung New protein conjugates and methods for their preparation |
| 06/07/2001 | DE19955607A1 Medikament oder aufeinander abgestimmte Kombination von Medikamenten Drug or combination of drugs concerted |
| 06/07/2001 | DE19948434A1 Substanzbibliothek enthaltend bicyclische Imidazo-5-amine und/oder bicyclische Imidazo-3-amine Substance library containing bicyclic imidazo-5-amines and / or bicyclic imidazo-3-amine |
| 06/07/2001 | CA2747954A1 Phosphonate compounds |
| 06/07/2001 | CA2696185A1 Use of taurolidine and derivatives thereof in the treatment of cancer by induction of apoptosis |
| 06/07/2001 | CA2393610A1 Transition metal-cyclopentadienyl-tropane conjugates |
| 06/07/2001 | CA2393440A1 Curcumin analogs with anti-tumor and anti-angiogenic properties |
| 06/07/2001 | CA2393252A1 Use of methylol-containing compounds to treat tumors |
| 06/07/2001 | CA2393217A1 Oxazolidinone derivatives |
| 06/07/2001 | CA2393193A1 Radiation protecting agent |
| 06/07/2001 | CA2393190A1 Substituted oxazoles and thiazoles derivatives as hppar alpha activators |
| 06/07/2001 | CA2393186A1 Attenuation of fibroblast proliferation |
| 06/07/2001 | CA2393179A1 Compounds specific to adenosine a1 a2a, and a3 receptors and uses thereof |
| 06/07/2001 | CA2392991A1 Semaphorin receptor |
| 06/07/2001 | CA2392979A1 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline crystal |
| 06/07/2001 | CA2392931A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 06/07/2001 | CA2392929A1 Novel benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same |
| 06/07/2001 | CA2392717A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | CA2392713A1 Novel antidiabetic agents |
| 06/07/2001 | CA2392615A1 Pancreatic stem cells and their use in transplantation |
| 06/07/2001 | CA2392507A1 Arylamine derivatives and their use as anti-telomerase agent |
| 06/07/2001 | CA2392504A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 06/07/2001 | CA2391646A1 Solid preparation |
| 06/07/2001 | CA2391402A1 Masp-3, a complement-fixing enzyme, and uses for it |
| 06/07/2001 | CA2390839A1 Transforming growth factor alpha hiii |
| 06/07/2001 | CA2390786A1 Compositions and methods for the treatment of immune related diseases |
| 06/07/2001 | CA2390349A1 Alpha-ketoamide inhibitors of hepatitis c virus ns3 protease |
| 06/07/2001 | CA2389368A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 06/06/2001 | EP1104807A2 Apparatus for the production of TGF-beta |
| 06/06/2001 | EP1104764A1 1h-imidazopyridine derivatives |
| 06/06/2001 | EP1104762A1 Substituted imidazo 1,2a]azines as selective inhibotors of cox-2 |
| 06/06/2001 | EP1104760A1 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents |
| 06/06/2001 | EP1104759A1 Heteroaryl phenyl pyrazole compounds as anti-inflammatory/analgesic agents |
| 06/06/2001 | EP1104758A1 Acetylene derivatives as anti-inflammatory/analgesic agents |
| 06/06/2001 | EP1104677A2 Proteinconjugates and their preparation |
| 06/06/2001 | EP1104674A1 O,o'-dihydroxy azo dyes as medicinal components with TPO-agonistic or -synergetic activity |
| 06/06/2001 | EP1104473A2 Proteases and associated proteins |
| 06/06/2001 | EP1104440A1 A g-protein coupled 7tm receptor (axor-1) |
| 06/06/2001 | EP1104422A1 Phenyl xanthine derivatives |
| 06/06/2001 | EP1104421A1 3-(4-amino-5-ethylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1h-pyrazolo 3,4-b]pyridine |
| 06/06/2001 | EP1104420A1 Substituted 1,8-naphthyridin-4(1h)-ones as phosphodiesterase 4 inhibitors |
| 06/06/2001 | EP1104413A2 Piperidine and piperazine derivatives, process for their preparation and pharmaceutical compounds containing them |
| 06/06/2001 | EP1104412A1 Tace inhibitors |
| 06/06/2001 | EP1104410A1 New carboxylic acid derivatives carrying keto side-chains, their production and their use as endothelin-receptor antagonists |
| 06/06/2001 | EP1104407A1 Compounds as selective agonists at alpha 2b or 2b/2c adrenergic receptors |
| 06/06/2001 | EP1104403A1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 06/06/2001 | EP1104309A2 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods |
| 06/06/2001 | EP1104307A2 Pharmaceutical composition having inhibitory effect on overproduction and accumulation of extracellular matrix |
| 06/06/2001 | EP1104298A2 Heterocyclic thioesters or ketones for vision and memory disorders |
| 06/06/2001 | EP1104294A1 Compositions and methods of treating abnormal cell proliferation |
| 06/06/2001 | EP1104293A1 Regulation of substrate activity |
| 06/06/2001 | EP1104289A2 New oral formulation for 5-ht4 agonists or antagonists |
| 06/06/2001 | EP1104281A1 Incorporation of exogenous lactic bacteria into the oral microflora |
| 06/06/2001 | EP1104247A1 Process and product for promoting weight loss in overweight dogs |
| 06/06/2001 | EP0889891B1 4-[(thien-2-yl)methyl]imidazole derivatives having alpha2-adrenoceptor agonistic activity |
| 06/06/2001 | EP0873329B1 Novel n-aminoalkylfluorenecarboxamides; a new class of dopamine receptor subtype specific ligands |
| 06/06/2001 | EP0802914B1 Aryl- and heteroaryl- purine and pyridopyrimidine derivatives |
| 06/06/2001 | EP0777659B1 Morpholine derivatives and their use as therapeutic agents |
| 06/06/2001 | EP0681584B1 Condensed heterocyclic glutamic acid derivatives as antiproliferative agents |
| 06/06/2001 | EP0673426B1 Platelet-activating factor acetylhydrolase |
| 06/06/2001 | EP0579626B1 Method and agents for promoting wound healing |
| 06/06/2001 | EP0536299B1 Surface complexed lymphotoxin |
| 06/06/2001 | CN1298412A G-CSF receptor agonist antibodies and screening method therefor |
| 06/06/2001 | CN1298406A Condensed thienopyrimidines with phosphodiesterase-V inhibiting action |
| 06/06/2001 | CN1298404A Inhibitors of phospholipase A2 |
| 06/06/2001 | CN1298394A Aryl fused azapolycyclic compounds |
| 06/06/2001 | CN1298393A Quinoline derivatives |
| 06/06/2001 | CN1298386A N-substituted aminotetralins as ligands for the neuropeptide YY5 receptor useful in the treatment of obesity and other disorders |
| 06/06/2001 | CN1298308A Inhibitors of complement activation |
| 06/06/2001 | CN1298298A Periadventitial delivery device |
| 06/06/2001 | CN1298296A Erythropoietin Liposomal dispersion |
| 06/06/2001 | CN1297888A 2-(3,5-=-trifluoromethyl-phenyl)-N methyl-N-(6-morpholine-4-radical-4-o-tolyl-pyridine-3-radical)-isobutyryl |
| 06/06/2001 | CN1297775A Cultivation of bezoar for oral veterinary medicine chenghuangling and its preparing method |
| 06/06/2001 | CN1297773A Production process for whole glossy ganoderma product |
| 06/06/2001 | CN1297771A Chinese medicine for treating bed body smell |
| 06/06/2001 | CN1297760A Fatigue resisting composition |
| 06/06/2001 | CN1066733C 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives |
| 06/06/2001 | CN1066732C Pyrido (2,3-b) pyrazine derivatives |
| 06/06/2001 | CN1066727C Anti-migraine indole derivative salts |
| 06/06/2001 | CA2328553A1 Novel derivatives (dihydro)benzoxazine and (dihydro)benzothiazine substitutes, process for preparing them and pharmaceutical compositions containing them |
| 06/05/2001 | US6242637 Substituted heterocylic compounds, method of preparing them and pharmaceutical compositions in which they are present |
| 06/05/2001 | US6242611 Phenylimidazolidines containing nitrooxy or carbonyloxy groups |